clarithromycin has been researched along with Connective Tissue Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hooper, M; Lesko, M; Moskowitz, RW | 1 |
| Bonnet, E; Debat-Zoguereh, D; Gallais, H; Petit, N; Ravaux, I | 1 |
2 other study(ies) available for clarithromycin and Connective Tissue Diseases
| Article | Year |
|---|---|
Open-label study of clarithromycin in patients with undifferentiated connective tissue disease.
Topics: Adult; Aged; Arthritis; Autoimmune Diseases; Chondrocalcinosis; Clarithromycin; Connective Tissue Diseases; Female; Humans; Male; Middle Aged; Patient Satisfaction; Protein Synthesis Inhibitors; Rheumatic Diseases | 2006 |
Clarithromycin: a potent agent against infections due to Mycobacterium marinum.
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Connective Tissue Diseases; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 1994 |